Mutagenic specificity of 2-acetylaminofluorene (AAF) has been established in mammalian cells and several strains of bacteria by using a shuttle plasmid vector containing a single N-(deoxyguanosin-8-yl)acetylaminofluorene (C8-dG-AAF) adduct. The nucleotide sequence of the gene conferring tetracycline resistance was modified by conservative codon replacement so as to accommodate the sequence d(CCTTCGCTAC) flanked by two restriction sites, Bsm I and Xho I. The corresponding synthetic oligodeoxynucleotide underwent reaction with 2-(N-acetoxy-N-acetylamino)-fluorene (AAAF), forming a single dG-AAF adduct. This modified oligodeoxynucleotide was hybridized to its complementary strand and ligated between the Bsm I and Xho I sites of the vector. Plasmids containing the C8-dG-AAF adduct were used to transfect simian virus 40-transformed simian kidney (COS-l) cells and to transform several AB strains of Escherichia coli. Colonies containing mutant plasmids were detected by hybridization to 32P-labeled oligodeoxynucleotides. Presence of the single DNA adduct increased the mutation frequency by 8-fold in both COS cells and E. coli. Over 80% of mutations detected in both systems were targeted and
fluorene (AAAF), forming a single dG-AAF adduct. This modified oligodeoxynucleotide was hybridized to its complementary strand and ligated between the Bsm I and Xho I sites of the vector. Plasmids containing the C8-dG-AAF adduct were used to transfect simian virus 40-transformed simian kidney (COS-l) cells and to transform several AB strains of Escherichia coli. Colonies containing mutant plasmids were detected by hybridization to 32P-labeled oligodeoxynucleotides. Presence of the single DNA adduct increased the mutation frequency by 8-fold in both COS cells and E. coli. Over 80% of mutations detected in both systems were targeted and represented G-C --CG or G-C-T-A transversions or single nucleotide deletions. We conclude that modification of a deoxyguanosine residue with AAF preferentially induces mutations targeted at this site when a plasmid containing a single C8-dG-AAF adduct is introduced into mammalian cells or bacteria.
Chemical mutagenesis often involves formation of a covalent adduct between the mutagen and DNA (1, 2) . Such lesions activate cellular mechanisms involved in DNA repair and, unless repaired prior to replication, may lead to nucleotide substitutions, deletions, and chromosome rearrangements (3) . Chemical mutagens are also reported to activate cellular protooncogenes (4) .
Primary chemical structures have been established for different DNA adducts (1, 2) . However, such information alone does not distinguish between potential mutagenic species; in fact, so called "minor" adducts may be more important in this respect than those detected in much larger quantities (1) .
Experiments in which cells are exposed to a given chemical mutagen involve a number of factors, including transport, metabolism, and the site of adduct formation. These processes complicate interpretation of subsequent mutagenic events. Furthermore, many methods used for detection of mutations, although sensitive and convenient, introduce selective bias into the mutagenic response and/or fail to detect silent mutations. In our experiments, these problems were obviated by initiating mutagenesis with a defined DNA adduct introduced at a specific site in the genome and by detecting the full spectrum of mutations by oligodeoxynucleotide hybridization.
Viral and plasmid vectors containing specifically located DNA adducts have been described (5) (6) (7) (8) ; some of these have been tested for mutagenic properties in bacteria (8) (9) (10) . We have constructed a shuttle plasmid containing a single "bulky" adduct, N-(deoxyguanosin-8-yl)acetylaminofluorene (C8-dG-AAF). This modified plasmid was allowed to replicate in mammalian cells and bacteria. In both experimental systems, the adduct generated a mutagenic response consisting primarily of transversions and single-base deletions targeted to the site of chemical modification.
MATERIALS AND METHODS
Construction of Plasmid Vector and 2-Acetylaminofluorene (AAF)-Modified Oligodeoxynucleotide. The shuttle plasmid pAG75 was constructed from the bacterial plasmid pKP772 by inserting the simian virus 40 origin of replication (11), nucleotides 5155-119, at the EcoRI site. Plasmid pKP772 was derived from pBR322 by deletion of nucleotides 1332-2520 (K.P., unpublished data). Oligonucleotidedirected mutagenesis (12) created unique Mlu I (nucleotide 945) and Xho I (nucleotide 978) sites in the tetracyclineresistance (TcR) gene (Fig. 1) . The 33-base-pair sequence between these restriction sites was replaced by a chemically synthesized oligonucleotide containing sites for SnaBI (nucleotide 956), Nhe I (nucleotide 964), and Bsm I (nucleotide 968), creating pGM86 (Fig. 1 ). After digestion with Bsm I and Xho I, pGM86 was used as vector for the mutagenesis studies described in this paper. Plasmid pGM87 was constructed by replacement of the short Bsm I/Xho I fragment with another synthetic oligodeoxynucleotide, d(CCTTCGCTAC) (G-10). Base substitutions introduced by these procedures conserve the original amino acid sequence; thus pGM86 and pGM87 retain a functional gene conferring TcR. This property is lost in plasmids containing a singlebase deletion or G -+ C mutation at position 974, the site of the dG-AAF adduct.
Oligodeoxynucleotide G-10 and its complementary strand, d(TCGAGTAGCGAAGGCT) (C-16) , were synthesized by solid-state methods, using conventional phosphoramidite chemistry (13) . After removal from the solid support, oligodeoxynucleotides were purified as their 5'-dimethyltrityl derivatives, using reversed-phase HPLC on a Bio-Sil ODS-5S column (Bio-Rad) (300 x 4.5 mm), eluting with a linear gradient of 15-30% acetonitrile in 0.05 M triethylammonium acetate buffer (pH 7.0). The main UV-absorbing fraction was Abbreviations: AAAF, N-acetoxy-2-(acetylamino)fluorene; AAF, 2-acetylaminofluorene; C8-dG-AAF, N-(deoxyguanosin-8-yl)acetylaminofluorene; TcR, tetracycline resistance.
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G-10 (0.1 mg) and N-acetoxy-2-(acetylamino)fluorene (AAAF) (0.5 mg) were dissolved in 1.0 ml of sodium citrate buffer containing 10%6 ethanol and allowed to stand for 90 min at 370C under nitrogen in the dark. HPLC analysis of the reaction products, eluted over 10 min with a linear 0-20% gradient of acetonitrile in triethylammonium acetate buffer followed by an isocratic 20o elution, revealed a new UVabsorbing peak, eluting at 23.5 min, which was clearly resolved from unmodified G-10, eluting at 21.6 min. The UV spectrum of this modified oligodeoxynucleotide exhibited an absorption maximum at 270 nm with a shoulder at 300 nm. After phosphorylation with (y -32P]ATP and T4 polynucleotide kinase, the modified product (G-10-AAF) could be resolved from the slightly faster-migrating G-10 by electrophoresis on a 20%o polyacrylamide gel.
G-10-AAF was analyzed by degradation with spleen phosphodiesterase (10 mM MgCl2) and alkaline phosphatase (14) followed by HPLC. The mobile phase was provided by a 0-60%o linear gradient of acetonitrile in triethylammonium acetate buffer. The column was eluted over 30 min with a flow rate of 0.7 ml/min and the major product, appearing at the same position as authentic C8-dG-AAF (27.5 min), was clearly resolved from N-(deoxyguanosin-8-yl)aminofluorene (28.7 min) and 3-(deoxyguanosin-N2-yl)acetylaminofluorene (25.5 min). Treatment of G-10-AAF with trifluoroacetic acid (15) , followed by HPLC, produced a single product that cochromatographed with guanyl-AAF.
Mutagenesis in Escherichia coli. The unmodified and AAFmodified oligodeoxynucleotides, G-10 and G-10-AAF, were phosphorylated at the 5 tSpecific alterations are shown in Fig. 2 . *One mutation was accompanied by an alteration at another site and is listed accordingly.
being deletions. The majority of alterations in mutants isolated from COS cells in each of several experiments represented nucleotide substitutions; 10%6 were deletions. Of the nucleotide substitution mutations observed in E. coli, >90%o were transversions, G-C -C G predominating over G-C -+ TEA. In COS cells, 95% of these mutations were transversions; the two types occurred with similar frequency. Background Mutations and Mutations Occurring at Sites Other than Nucleotide 974. While =1% of the colonies recovered after transformation of E. coli or transfection of COS cells with pGM87 contained mutations within the specified region of the TcR gene, no changes were found at position 974 (Fig. 2) . A similar spectrum of changes was found in experiments with pGM87-AAF, although the majority of mutations in this case occurred at the site of the adduct (Table 1) Double-nucleotide substitutions involving base substitution mutations at and adjacent to the site of modification were found in AB1157 and COS cells. The C&G pair 3' to position 974 mutated to APT in pGM87-transformed AB1157. In AB1886, using pGM87-AAF, addition of a single C-G pair occurred at the same position.
DISCUSSION
We have developed an experimental system that should be widely applicable to studies of mutagenic specificity in mammalian cells and bacteria. Due to the diversity of adducts produced by certain mutagens, it is desirable to relate the mutations produced to the structure and position of a given lesion. In conducting such experiments, it is essential to establish the degree of homogeneity and purity of the mutagenic species so that experimental results are not confounded by the presence of minor components (23) . For example, the frequency of untargeted mutations created by synthetic oligonucleotides in our experiments is apparently higher than in the naturally occurring bases of the TcR gene. This increased frequency of background mutations may reflect the error rate reported (24) when automated solidstate chemical methods are used to prepare DNA.
Over 80%o of the mutations detected in our study were transversions or single-base deletions occurring exclusively at the AAF-modified base. While C-G --T-A transitions 5' to the modified base arise as background mutations, the increased number of mutations at the same site may relate to the presence of the adduct. These results should be compared to the mutagenic spectrum described by KoffelSchwartz et al. (25) in which a fragment of pBR322, modified randomly with AAF, was used to transform E. coli. More than 90%o of the changes reported in this study were frameshift mutations.
Fuchs and co-workers also reported that mutations created by AAF adducts arose only when adducts were introduced in both strands and host cells were irradiated with ultraviolet light (26) . In their experiments, the modified strand contains an average of three AAF adducts and leads to a significant decrease in transformation efficiency. The presence of several AAF adducts located on a single template strand is likely to impede DNA synthesis (27) ; under these conditions, the unmodified complementary strand appears to be selectively copied (26) . In our experiments, we observed an increase in mutation frequency without marked diminution of transformation efficiency. There was no apparent requirement for induction of SOS functions. A lesser increase of mutation frequency was recorded for the single recA strain tested (28) .
The nucleotide sequence in which the C8-dG-AAF adduct is located may play an important role in determining the nature of mutations produced. The single adduct in our modified plasmid was introduced at position 974; this site is located in a pyrimidine-rich sequence. The effect of neigh-boring bases on the mutagenicity of C8-dG-AAF or other arylamine adducts may be ascertained more readily in sequences containing more than one deoxyguanosine residue.
Mutations resulting from treatment of bacteria with carcinogenic agents generally occur opposite premutational lesions (29) . In our experiments, the majority of mutations created by the bulky adduct C8-dG-AAF are also targeted to the site of the lesion. Our assay detects phenotypic changes within the TcR gene that arise from mutations outside the targeted region; there was no increase in the number of such mutations in either COS cells or bacteria. The few untargeted mutations observed in the vicinity of the AAF adduct are concentrated at the position immediately 5' to the modified base.
The mutagenic response to C8-dG-AAF in mammalian cells was similar to that observed in bacteria. This observation suggests that these mutations are governed by a mispairing or misreading phenomenon, possibly created by conformational distortion of DNA (30, 31) . Our results predict a model in which an AAF-modified deoxyguanosine residue preferentially directs incorporation of dGTP and, to a lesser extent, dATP, into DNA. Such misincorporation of deoxynucleotides could be facilitated if the deoxyguanosine moiety of the adduct adopted the syn conformation (32, 33) .
AAAF reacts at the C-8 position of deoxyguanosine to form a stable covalent adduct with DNA. This AAF adduct could conceivably be deacetylated by cellular enzymes to form N-(deoxyguanosin-8-yl)aminofluorene or depurinated to produce an abasic site (34) . We cannot exclude the possibility that some of the mutational changes observed in our experiments arise from these lesions. These questions can now be explored systematically by directly incorporating N-(deoxyguanosin-8-yl)aminofluorene adducts (7) and abasic sites (35) into oligodeoxynucleotides and testing their mutagenic specificity by the methods described in this paper.
